11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
On January 1, 2020, California’s new worker classification law known as Assembly Bill 5 (“AB 5”),...
Read More >
There has been a significant change regarding what construction is considered “essential” and may ...
Read More >
In this Town Hall session, Domenique Camacho Moran, Partner and Head of the Labor & Employment Pract...
Read More >
Trade secrets can be stolen at any point, and such theft can be prosecuted by the Department of Just...
Read More >
On this episode of Williams Mullen's Benefits Companion, Brydon DeWitt reviews the final health reim...
Read More >
There is an old joke that a camel is a horse that has been designed by a committee. We all know that...
Read More >